RU97112927A - NEW AMINO-OLIGOSACCHARIDE DERIVATIVE AND METHOD FOR PRODUCING IT - Google Patents

NEW AMINO-OLIGOSACCHARIDE DERIVATIVE AND METHOD FOR PRODUCING IT

Info

Publication number
RU97112927A
RU97112927A RU97112927/04A RU97112927A RU97112927A RU 97112927 A RU97112927 A RU 97112927A RU 97112927/04 A RU97112927/04 A RU 97112927/04A RU 97112927 A RU97112927 A RU 97112927A RU 97112927 A RU97112927 A RU 97112927A
Authority
RU
Russia
Prior art keywords
producing
pharmaceutically acceptable
acceptable salts
integer
new amino
Prior art date
Application number
RU97112927/04A
Other languages
Russian (ru)
Other versions
RU2134694C1 (en
Inventor
Ву Ким Джунг
Му Ли Кванг
Сик Чун Хнюнг
Гван Ким Джонг
Бае Чанг Хунг
Хо Ким Сун
Бок Мин Кненг
Сик Мун Кеюнг
Original Assignee
Чонг Кун Данг Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019940039755A external-priority patent/KR960022566A/en
Application filed by Чонг Кун Данг Корпорейшн filed Critical Чонг Кун Данг Корпорейшн
Publication of RU97112927A publication Critical patent/RU97112927A/en
Application granted granted Critical
Publication of RU2134694C1 publication Critical patent/RU2134694C1/en

Links

Claims (4)

1. Аминоолигосахарид СК-4416, представленный общей формулой (I), и его фармацевтически пригодные соли:
Figure 00000001

отличающееся тем, что:
m равно целому числу 0 или 1;
n равно целому числу от 1 до 4;
m + n равно целому числу от 1 до 5;
R1 обозначает низший алкилгидроксид; и
R2 обозначает водород или низший алкил.1. Amino-oligosaccharide SK-4416 represented by the general formula (I) and pharmaceutically acceptable salts thereof:
Figure 00000001

characterized in that:
m is an integer of 0 or 1;
n is an integer from 1 to 4;
m + n is an integer from 1 to 5;
R 1 is lower alkyl hydroxide; and
R 2 is hydrogen or lower alkyl. 2. Ингибитор сахаридгидролазы, содержащий в качестве активных ингредиентов СК-4416 и его фармацевтически пригодные соли по п.1. 2. A saccharide hydrolase inhibitor containing SK-4416 and its pharmaceutically acceptable salts as active ingredients according to claim 1. 3. Антибактериальный агент, содержащий в качестве активных ингредиента СК-4416 и его фармацевтически пригодные соли по п.1. 3. An antibacterial agent containing as active ingredient SK-4416 and its pharmaceutically acceptable salts according to claim 1. 4. Способ получения СК-4416 и его фармацевтически приемлемых солей по п. 1, включающий стадии культивирования Streptomyces вида СК-4416 (КСТС 0131 ВР) и выделения СК-4416. 4. A method for producing SK-4416 and its pharmaceutically acceptable salts according to claim 1, comprising the steps of cultivating Streptomyces type SK-4416 (KSTS 0131 BP) and isolating SK-4416.
RU97112927/04A 1994-12-30 1995-12-30 Aminooligosaccharide "sk-4416", method of its synthesis, inhibitor of saccharide hydrolase and antibacterial agent RU2134694C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1994/39755 1994-12-30
KR1019940039755A KR960022566A (en) 1994-12-30 1994-12-30 Novel aminooligosaccharide derivatives and preparation method thereof
PCT/KR1995/000184 WO1996020945A1 (en) 1994-12-30 1995-12-30 Novel aminooligosaccharide derivative and process for preparing the same

Publications (2)

Publication Number Publication Date
RU97112927A true RU97112927A (en) 1999-06-10
RU2134694C1 RU2134694C1 (en) 1999-08-20

Family

ID=19405792

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97112927/04A RU2134694C1 (en) 1994-12-30 1995-12-30 Aminooligosaccharide "sk-4416", method of its synthesis, inhibitor of saccharide hydrolase and antibacterial agent

Country Status (10)

Country Link
US (1) US5866377A (en)
EP (1) EP0871638B1 (en)
JP (1) JP2863637B2 (en)
KR (2) KR960022566A (en)
CN (1) CN1051559C (en)
AU (1) AU686920B2 (en)
CA (1) CA2208707C (en)
DE (1) DE69527445T2 (en)
RU (1) RU2134694C1 (en)
WO (1) WO1996020945A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022684B2 (en) 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
ES2555106T3 (en) 2010-04-05 2015-12-29 Prognosys Biosciences, Inc. Spatially coded biological assays
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
DK3013983T3 (en) 2013-06-25 2023-03-06 Prognosys Biosciences Inc SPATIALLY ENCODED BIOLOGICAL ASSAYS USING A MICROFLUIDIC DEVICE
JP6828007B2 (en) 2015-04-10 2021-02-10 スペーシャル トランスクリプトミクス アクチボラグ Spatial-identified multiplex nucleic acid analysis of biological samples

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58172400A (en) * 1982-04-05 1983-10-11 Tokyo Tanabe Co Ltd Novel amino oligosaccharide derivative
ATE89563T1 (en) * 1986-08-13 1993-06-15 Hoechst Ag OXIRAN-PSEUDOOLIGOSACCHARIDES, PROCESSES FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL PREPARATIONS.
JPH0319239A (en) * 1989-06-15 1991-01-28 Matsushita Electron Corp Manufacture of semiconductor device

Similar Documents

Publication Publication Date Title
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
HU9603521D0 (en) Method for stabilizing duocarmycin derivatives
ES2132415T3 (en) NEW DERIVATIVES OF 5-PIRROLIL-2-PIRIDILMETILSULFINILBENCIMIDAZOL.
ATE362755T1 (en) STABLE COMPOSITIONS CONTAINING N-PROPARGYL-1-AMINOINDANE
HK1003708A1 (en) Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
EP0667330A4 (en)
RU94044436A (en) Method of suppression of skin and vagina atrophy
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
ATE215827T1 (en) IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPIDS
CA2015475A1 (en) Treating agent for osteoarthritis
RU93005069A (en) NEW TRIAZOLE DERIVATIVES, METHOD OF THEIR PRODUCTION AND INSECTICID-ACARICIDAL COMPOSITION
RU94044456A (en) Agent for suppression of dysfunctional uterine bleeding
RU97112927A (en) NEW AMINO-OLIGOSACCHARIDE DERIVATIVE AND METHOD FOR PRODUCING IT
CA2365359A1 (en) Medicaments containing a sulfopyranosylglycerol derivative
CA2129542A1 (en) Pharmaceutical preparation based on rhamnolipid
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
KR950703941A (en) Nitrogen monoxide synthase inhibitor (NITROGEN MONOXIDE SYNTHESIS INHIBITOR)
CA2020474A1 (en) Antiinflammatory and/or antiallergic composition
IL112432A0 (en) Fatty acid derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
RU98103388A (en) (R) -5-BROM-N- (1-ETHYL-4-Methylhexagidro-1H-1,4-Diazepin-6-IL) -2-METHOXI-6-M COMPOSITION CONTAINING THE SPECIFIED CONNECTION
EA199700136A1 (en) METHODS OF INHIBITING EXOGENOUS ESTROGENS
HUT68190A (en) Process for producing ergoline derivatives of serotoninergic activity
KR900009677A (en) New compounds
CA2025858A1 (en) Antihepatopathic composition
KR920002594A (en) 5-isothiazolamine derivative